Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report

Saved in:
Bibliographic Details
Published in:Lung Cancer: Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552400343662592
collection WordPress RSS
FRELIP Feed Integration
container_title Lung Cancer: Targets and Therapy
description
discipline_display Respiratory Diseases
discipline_facet Respiratory Diseases
format Online Article
RSS Article
genre Journal Article
id rss_article:58415
institution FRELIP
journal_source_facet Lung Cancer: Targets and Therapy
last_indexed 2026-06-20T21:19:56.163Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
Respiratory Diseases
General
Respiratory Diseases
sub_discipline_display General
sub_discipline_facet General
subject_display Respiratory Diseases
General
Respiratory Diseases
subject_facet Respiratory Diseases
General
Respiratory Diseases
title Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_alt Agonista del receptor de incretina, semaglutida, como tratamiento para el aumento de peso excesivo inducido por alectinib. Reporte de un caso
Agoniste du récepteur des incrétines, sémaglutide, comme traitement de la prise de poids excessive induite par l'alectinib. Rapport de cas
Agonista do Receptor de Incretina, Semaglutida, como Tratamento para Ganho de Peso Excessivo Induzido por Alectinibe. Um Relato de Caso
title_auth Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_es_txt Agonista del receptor de incretina, semaglutida, como tratamiento para el aumento de peso excesivo inducido por alectinib. Reporte de un caso
title_fr_txt Agoniste du récepteur des incrétines, sémaglutide, comme traitement de la prise de poids excessive induite par l'alectinib. Rapport de cas
title_full Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_fullStr Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_full_unstemmed Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_pt_txt Agonista do Receptor de Incretina, Semaglutida, como Tratamento para Ganho de Peso Excessivo Induzido por Alectinibe. Um Relato de Caso
title_short Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
title_sort incretin receptor agonist, semaglutide, as a treatment for alectinib-induced excessive weight gain. a case report
topic Respiratory Diseases
General
Respiratory Diseases
url https://www.dovepress.com/incretin-receptor-agonist-semaglutide-as-a-treatment-for-alectinib-ind-peer-reviewed-fulltext-article-LCTT